OrganiGram

Organigram integrates the Sanity Group and appoints Finn Age Hänsel as President, Rest of World & Chief Strategy Officer and Adrian Frenzel as Global Chief Operating Officer; Tim Emberg remains President Canada. The acquisition's earn‑out clause was converted into a fixed earn‑out (85% of the original maximum): €20m in cash and about €76m in Organigram shares, payable no later than May 1, 2027; the number of shares is based on the 20‑day VWAP with a minimum price of C$3 and a maximum of C$4. Sanity most recently contributed about CAD 40m to Organigram's quarterly revenue (more than 35%); Sanity's quarterly revenue increased 34% to CAD 25.5m. The combined distribution network is expected to span Canada, Germany, Switzerland, Poland, the Czech Republic, the UK and Australia. » More on de.investing.com

OrganiGram reported net revenue of CAD 105.8m in the third fiscal quarter (+49% year-on-year) and adjusted EBITDA of CAD 13.4m (+136%). A key driver was the first-time near-full consolidation of the Sanity Group, which has contributed about CAD 40m since acquisition and lifted international revenue to roughly 35%. Adjusted gross margin improved to 37% and management expects revenue above CAD 350m for 2026, but still sees negative free cash flow for the full year due to working capital needs. The stock rose about 4.4% premarket to USD 1.43, while liquidity and integration costs remain risk factors. » More on de.investing.com

Organigram Global will publish results for the quarter ended June 30, 2026, on August 11, 2026. A consensus of four analysts expects EPS of -0.010 CAD per share versus -0.050 CAD a year ago. Five analysts forecast revenue to rise 36.8% to 96.9 million CAD and, for the current fiscal year, an average EPS of 0.120 CAD and annual revenue of 336.2 million CAD. » More on finanzen.net